Lesson 2 of 12
How to Read a Monograph — Sources, Cross-Checking, Bias
A working herbalist reads every plant monograph the way a journalist reads a press release — carefully, with sourcing and bias in mind.
Most herbal monographs you will encounter are well-intentioned, partially sourced, and confidently certain. Some are well-researched. A few are wrong about important things. Reading them critically is a working skill, not a once-and-done activity.
What a monograph is A monograph is a structured entry on a single plant. Typical fields: Latin binomial, common names, family, parts used, energetic profile, traditional uses, modern clinical research, constituents, actions, indications, contraindications, drug interactions, dose, preparation methods, safety notes, source references. Different monographs include different subsets of these.
The level of trustworthiness varies enormously by source.
The trust hierarchy
**Tier 1 — pharmacopoeial monographs.** The American Herbal Pharmacopoeia, the European Scientific Cooperative on Phytotherapy (ESCOP), the British Herbal Pharmacopoeia, the Commission E monographs from Germany, and the World Health Organization monographs are written by panels of experts, peer-reviewed, and sourced rigorously. The AHP monographs run 80-150 pages each on a single plant and are the closest thing in the field to a fully reliable source. They cost $50-100 each. If you are going to invest in one plant deeply, the AHP monograph is where to start.
**Tier 2 — peer-reviewed textbook references.** Mills & Bone's *Principles and Practice of Phytotherapy* and Hoffmann's *Medical Herbalism* are the dominant English-language clinical references. Both are written by clinically experienced practitioners with active research backgrounds. Both cite primary literature. Disagreements between them are rare and instructive.
**Tier 3 — practitioner-experience books.** Matthew Wood's books, Stephen Buhner's books, Susun Weed's books, Rosemary Gladstar's books, and many others are written by experienced practitioners drawing on their own clinical work. They are excellent for getting a sense of how a plant feels in practice. They are weaker on biochemistry and on cross-referenced safety information. Read them in conversation with Tier 1 and Tier 2 sources, not as standalone references.
**Tier 4 — websites, blogs, social media.** Variable quality. Some are written by serious herbalists; some are written by content marketers; most are somewhere in between. The single biggest red flag: a monograph that lists fifteen conditions a plant treats and provides no source citations is not a reliable monograph. Treat as inspiration to do more research, not as a settled reference.
**Tier 5 — supplement-marketing copy.** Every claim is suspect because every claim is a sales prompt. Useful only for finding out what the marketers are willing to claim, not for what is true.
What to look for when you read
**Sources.** Are claims tied to specific references? Are those references primary research or are they other monographs? A monograph that cites "traditional use" without specifying the tradition, the source, or the era is making a confident claim with no actual evidence. Sometimes the claim is right; sometimes it is one practitioner's pet theory repeated five times until it became "traditional."
**Dose specifics.** A monograph that says "take as needed" or "use according to product label" is not telling you anything. A monograph that says "1:5 tincture at 50%, 30-60 drops three times daily for an average adult, reduce for children and elders, contraindicated in pregnancy" is doing real work.
**Contraindications.** A monograph that lists no contraindications for a strong plant is suspicious. Almost every effective herb has contraindications somewhere — pregnancy, lactation, certain drug interactions, specific health conditions. A monograph that admits this is more trustworthy than one that does not.
**Bias.** Every author has a perspective. A monograph by someone who sells the plant has a financial interest in saying it works. A monograph by an Ayurvedic practitioner will frame the plant in Ayurvedic terms; a monograph by a TCM practitioner will frame it differently; a Western practitioner will frame it differently again. Recognize the perspective, do not be controlled by it.
**Date.** Older monographs have older safety data — fewer drug interactions noted because there were fewer drugs to interact with. A 1985 monograph on St. John's Wort does not mention the CYP450 interactions that became clinically obvious in the late 1990s. Cross-check old sources with newer ones for safety information specifically.
The cross-checking discipline For any plant you are about to use clinically, the working practice is: read at least three independent monographs from different tiers. If they all agree on the major points, your confidence is high. Where they disagree, dig into why. The disagreements are usually the most informative parts of the research.
For plants you have not used before, the threshold should be higher — read four or five sources, including at least one Tier 1 or Tier 2 reference, before using the plant clinically.
For plants in safety-sensitive populations (pregnancy, lactation, pediatric, polypharmacy elders), the threshold is higher still — pharmacopoeial monograph, current peer-reviewed safety review, and a conversation with a more experienced practitioner if you have one.
How to handle contradictions Two reputable sources sometimes disagree. The strategies for resolving the disagreement, in order:
1. Look at the primary literature. Often the disagreement is about how to interpret the same studies; reading the studies yourself resolves it.
2. Look at when each source was written. The more recent one usually has better data, but not always.
3. Look at the author's clinical orientation. A Western-clinical author and a traditional-Ayurvedic author may both be right about the same plant in different contexts.
4. Default to the safer interpretation. If one source says "contraindicated in pregnancy" and another does not address pregnancy, treat as contraindicated.